Science and Health News

Researchers at the University of Strathclyde have launched a clinical investigation which could eventually help millions of osteoporosis sufferers by harnessing pioneering ‘nanokicking’ technology – tiny vibrations to turn stem cells into healthy bone.

Scientists at USC Michelson Center for Convergent Bioscience and Japan’s Nagoya University find and test a promising drug that stops cancer by interfering with the cancer cells’ metabolism and other circadian-related functions.

UB researchers corrected synaptic dysfunctions in the brain involved in memory loss, using an epigenetic approach

Researchers from the Spanish centre Embryotools —with headquarters in the Barcelona Science Park (Parc Científic de Barcelona, PCB) — are participating in a landmark scientific event in Greece that will shape the future of assisted reproduction. In a pilot clinical trial conducted on women, which is being sponsored by the assisted reproduction centre Institute of Life in Athens, Spanish scientists have achieved the world’s first pregnancy that uses the Maternal Spindle Transfer technique to solve problems of infertility.

A tiny capsule, a string and a 2-centimeter sponge are the future of screening for deadly disease

Researchers from the Netherlands Institute for Neuroscience (NIN) and the Leiden University Medical Center (LUMC) have shown that treatment using gene therapy leads to a faster recovery after nerve damage. By combining a surgical repair procedure with gene therapy, the survival of nerve cells and regeneration of nerve fibers over a long distance was stimulated for the first time. The discovery, published in the journal Brain, is an important step towards the development of a new treatment for people with nerve damage.

Scientists at EPFL and ETH Zurich have developed tiny elastic robots that can change shape depending on their surroundings. Modeled after bacteria and fully biocompatible, these robots optimize their movements so as to get to hard-to-reach areas of the human body. They stand to revolutionize targeted drug delivery.

Insulin-producing cells more responsive to fluctuating glucose levels